A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.51 USD -0.7% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amneal Intermediate Inc
Total Current Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Total Current Liabilities
$846.6m
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
19%
Johnson & Johnson
NYSE:JNJ
Total Current Liabilities
$51.8B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
8%
Bristol-Myers Squibb Co
NYSE:BMY
Total Current Liabilities
$23.3B
CAGR 3-Years
7%
CAGR 5-Years
19%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Total Current Liabilities
$43.8B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
8%
Merck & Co Inc
NYSE:MRK
Total Current Liabilities
$26.1B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Total Current Liabilities
$27.1B
CAGR 3-Years
22%
CAGR 5-Years
18%
CAGR 10-Years
14%

See Also

What is Amneal Intermediate Inc's Total Current Liabilities?
Total Current Liabilities
846.6m USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Total Current Liabilities amounts to 846.6m USD.

What is Amneal Intermediate Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
19%

Over the last year, the Total Current Liabilities growth was 12%. The average annual Total Current Liabilities growth rates for Amneal Intermediate Inc have been 8% over the past three years , 9% over the past five years , and 19% over the past ten years .

Back to Top